Role of Lipopolysaccharides in the Inflammation and Pyroptosis of Alveolar Epithelial Cells in Acute Lung Injury and Acute Respiratory Distress Syndrome
Xiao Shen,Linglin He,Wanru Cai
DOI: https://doi.org/10.2147/jir.s479051
IF: 4.5
2024-09-02
Journal of Inflammation Research
Abstract:Xiao Shen, 1, &ast Linglin He, 2, &ast Wanru Cai 3 1 The Second Clinical Medical College, Zhejiang Chinese Medical University, Hangzhou, 310053, People's Republic of China; 2 School of Basic Medical Sciences, Zhejiang Chinese Medical University, Hangzhou, 310053, People's Republic of China; 3 Department of Respiratory and Critical Care Medicine, The Second Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou, 310005, People's Republic of China &astThese authors contributed equally to this work Correspondence: Wanru Cai, Department of Respiratory and Critical Care Medicine, The Second Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou, 310005, People's Republic of China, Email Acute lung injury (ALI) and acute respiratory distress syndrome (ARDS) represent a spectrum of common critical respiratory conditions characterized by damage and death of alveolar epithelial cells (AECs). Pyroptosis is a form of programmed cell death with inflammatory characteristics, and activation of pyroptosis markers has been observed in AECs of patients with ALI/ARDS. Lipopolysaccharides (LPS) possess strong pro-inflammatory effects and are a crucial pathological factor leading to ALI in patients and animals. In LPS-induced ALI models, AECs undergo pyroptosis. However, physiologically and pathologically relevant concentrations of LPS lead to minor effects on AEC cell viability and minimal induction of cytokine release in vitro and do not induce classical pyroptosis. Nevertheless, LPS can enter the cytoplasm directly and induce non-classical pyroptosis in AECs when assisted by extracellular vesicles from bacteria, HMGB1, and pathogens. In this review, we have explored the effects of LPS on AECs concerning inflammation, cell viability, and pyroptosis, analyzing key factors that influence LPS actions. Notably, we highlight the intricate response of AECs to LPS within the framework of ALI and ARDS, emphasizing the variable induction of pyroptosis. Despite the minimal effects of LPS on AEC viability and cytokine release in vitro, LPS can induce non-classical pyroptosis under specific conditions, presenting potential pathways for therapeutic intervention. Collectively, understanding these mechanisms is crucial for the development of targeted treatments that mitigate the inflammatory responses in ALI/ARDS, thereby enhancing patient outcomes in these severe respiratory conditions. Keywords: alveolar cell death, inflammatory response, programmed cell death, pathological impact, cytokine activation Acute lung injury (ALI) is characterized by an uncontrolled inflammatory response that leads to acute noncardiogenic pulmonary edema and hypoxemia. 1 With further deterioration, ALI can progress to acute respiratory distress syndrome (ARDS), which is clinically characterized by progressive respiratory distress and refractory hypoxemia. 2 Currently, the primary drugs used in clinical ARDS treatment include steroids, monoclonal antibodies, and small-molecule inhibitors. 2 However, these drugs have significant side effects, high treatment costs, and cannot reverse the condition in all patients with ARDS, with mortality rates persisting at 27.5–53%. 3,4 Damage and death of alveolar epithelial cells (AECs) are typical features of ALI, and the severity of lung epithelial damage serves as a crucial prognostic factor in patients with ARDS. 5–8 Various factors, including bacteria, viruses, acids, elevated oxygen levels, mechanical ventilation, and cytokines, can cause AEC injury. 1 In a healthy alveolar–capillary barrier, the pulmonary epithelial structure comprises a tight layer of type I and scattered type II AECs. Disruption of this barrier through type I AEC damage permits extensive fluid entry into alveolar spaces, resulting in pulmonary edema. After injury, reduced surfactant protein secretion by type II AECs leads to alveolar collapse. 9 AECs release pro-inflammatory cytokines (such as tumor necrosis factor alpha [TNF-α] and interleukin [IL]-1β) and damage-associated molecular patterns (such as nucleic acids and HMGB1), exacerbating pulmonary inflammation and leading to a detrimental cycle in the microenvironment. 10,11 Lipopolysaccharides (LPS) are found in the cell walls of gram-negative bacteria and comprise three parts: O-specific side chains, core polysaccharides, and lipid A, with lipid A serving as the main toxic component. During gram-negative bacterial infections, the release of large amounts of LPS by these bacteria can lead to severe ALI and sepsis, positioning LPS as a pivotal pathological factor in sepsis and ALI/ARDS. 12 The LPS model is widely utilized in animal studies of ALI/ARDS, reflecting pathologic -Abstract Truncated-
immunology